EP17.06-01 COVID-19 Long-Lasting Effect on Lung Cancer Diagnoses in Italy: Update of the Real-World Multicenter COVID-DELAY Study

Since the outbreak of coronavirus disease 2019 (COVID-19), Oncology has been largely derailed. Italy was the first and most severely affected European country. The repercussions on cancer patients’ outcome have been globally suggested to resonate in the years to come. We previously presented a decline in lung cancer (LC) diagnoses in 2020, paralleled by the rising incidence of stage IV LC compared to 2019. As part of the extended analysis of the COVID-DELAY study, we aimed to assess COVID-19 impact on diagnosis, staging and treatment outcomes of LC patients in 2021 and 2022 compared to 2019 and 2020.